These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8597934)

  • 1. Protestors say "non" to HIV drug lottery.
    Tastemain C
    Nat Med; 1996 Apr; 2(4):376. PubMed ID: 8597934
    [No Abstract]   [Full Text] [Related]  

  • 2. Abbott protease inhibitor lottery in January, CD4 under 50--registration now.
    AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How 'bout that ritonavir?
    Notes Undergr; 1996 Jan; (no 31):5. PubMed ID: 11363356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2000 PWAs to get ritonavir via expanded access.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors: a tale of two companies.
    Cohen J
    Science; 1996 Jun; 272(5270):1882-3. PubMed ID: 8658156
    [No Abstract]   [Full Text] [Related]  

  • 6. Results on new AIDS drugs bring cautious optimism.
    Cohen J
    Science; 1996 Feb; 271(5250):755-6. PubMed ID: 8628987
    [No Abstract]   [Full Text] [Related]  

  • 7. Ritonavir, Abbott protease inhibitor, approved.
    AIDS Treat News; 1996 Mar; (no 243):2-3. PubMed ID: 11363300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS drugs lurch towards market.
    Steele F
    Nat Med; 1995 Apr; 1(4):285-6. PubMed ID: 7585051
    [No Abstract]   [Full Text] [Related]  

  • 9. Expanded access for experimental AIDS drugs.
    Barr D; Gilden D
    GMHC Treat Issues; 1995 Sep; 9(9):2. PubMed ID: 11362908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ritonavir (Abbott protease inhibitor) proves survival benefit in late-stage AIDS.
    James JS
    AIDS Treat News; 1996 Feb; (no 240):2-4. PubMed ID: 11363184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abbott: major protest over lack of access.
    AIDS Treat News; 1995 May; (no 223):7. PubMed ID: 11362468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ritonavir for advanced HIV infection.
    Am Fam Physician; 1996 Jul; 54(1):372, 374. PubMed ID: 8677846
    [No Abstract]   [Full Text] [Related]  

  • 13. Second protease inhibitor approved for HIV therapy.
    Am J Health Syst Pharm; 1996 Apr; 53(8):832. PubMed ID: 8728378
    [No Abstract]   [Full Text] [Related]  

  • 14. Protease inhibitors: patient education critical.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):1-3. PubMed ID: 11363303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitors show promise in HIV infection.
    Nelson H
    Lancet; 1996 Feb; 347(8998):383. PubMed ID: 8598709
    [No Abstract]   [Full Text] [Related]  

  • 16. New HIV drugs approved after some deal-making.
    Cimons M
    Nat Med; 1996 Apr; 2(4):376-7. PubMed ID: 8597935
    [No Abstract]   [Full Text] [Related]  

  • 17. Abbott agrees to implement a compassionate use program for Ritonavir.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):38. PubMed ID: 11362798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [For the first time a combination of 2 protease inhibitors investigated].
    Schenk M
    Dtsch Med Wochenschr; 1996 Aug; 121(34-35):A36. PubMed ID: 8829900
    [No Abstract]   [Full Text] [Related]  

  • 19. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abbott agrees to expanded access for ritonavir.
    Baker R
    BETA; 1995 Sep; ():4. PubMed ID: 11362891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.